-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CQmm9GDAWcgXbdkmlvfxugPBj9Ub3UhaZfKve2G1NJmExMBMyaLn1Qn80ofVRR0W ZVGJR1rktouTNLTqvy5AqA== 0001127602-10-014990.txt : 20100520 0001127602-10-014990.hdr.sgml : 20100520 20100520171925 ACCESSION NUMBER: 0001127602-10-014990 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100520 FILED AS OF DATE: 20100520 DATE AS OF CHANGE: 20100520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHON PAUL A CENTRAL INDEX KEY: 0001231589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 10848650 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-05-20 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231589 MAHON PAUL A 1 EVP & General Counsel Common Stock 2010-05-20 4 M 0 4000 27.97 A 29500 D Common Stock 2010-05-20 4 S 0 4000 51.3229 D 25500 D Stock Options 27.97 2010-05-20 4 M 0 4000 0 D 2008-03-15 2017-03-15 Common Stock 4000 33000 D This exercise of stock options and the corresponding sale of shares were carried out pursuant to the 10b5-1 Plan adopted by the reporting person on March 4, 2010. /s/ Paul A. Mahon 2010-05-20 -----END PRIVACY-ENHANCED MESSAGE-----